Skip to main content
Top
Published in: Child's Nervous System 7/2007

01-07-2007 | Original Paper

Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children

Authors: Peter Kan, John Kestle

Published in: Child's Nervous System | Issue 7/2007

Login to get access

Abstract

Objective

Shunt infection is a common and serious complication of cerebrospinal fluid (CSF) shunting most commonly caused by skin flora contamination at surgery. Recent studies indicate that the use of antibiotic-impregnated (AI) shunt systems may reduce the risk of postoperative shunt infections. We evaluated the incidence of shunt infections associated with the use of AI shunt catheters and compared it with the incidence associated with standard non-AI catheters.

Materials and methods

All shunt procedures performed by one surgeon using AI catheters were reviewed. An equal number of consecutive shunt procedures performed by the same surgeon using non-AI catheters were reviewed from the period immediately before the introduction of the AI system. Patients with <9 months of follow-up were excluded; all shunt infections and shunt-related complications were recorded. The proportions of infected shunts in the AI and control groups were compared using a χ 2 analysis.

Conclusion

We reviewed 160 shunt procedures (80 per group). The infection rate was 5.0% among patients with AI catheters compared with 8.8% in the control group (P = 0.534, Fischer’s exact). The average time to infection was similar between the two groups. Among the AI group, the shunt infection rate did not differ between ventricular catheter, distal catheter revisions, and revisions of ventricular and peritoneal tubing. In contrast with other reports, we found no significant reduction in the pediatric CSF shunt infection rate with the use of AI shunt systems. Any recommendation for or against the routine use of AI systems in children requires a prospective, blinded, randomized-controlled trial with adequate power.
Literature
1.
go back to reference Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML (2005) Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 21:56–61PubMedCrossRef Aryan HE, Meltzer HS, Park MS, Bennett RL, Jandial R, Levy ML (2005) Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 21:56–61PubMedCrossRef
2.
go back to reference Bayston R, Grove N, Siegel J, Lawellin D, Barsham S (1989) Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52:605–609PubMedCrossRef Bayston R, Grove N, Siegel J, Lawellin D, Barsham S (1989) Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52:605–609PubMedCrossRef
3.
go back to reference Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE (1995) Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 136:1–7CrossRef Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE (1995) Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 136:1–7CrossRef
4.
5.
go back to reference Chapman PH, Borges LF (1985) Shunt infections: prevention and treatment. Clin Neurosurg 32:652–664PubMed Chapman PH, Borges LF (1985) Shunt infections: prevention and treatment. Clin Neurosurg 32:652–664PubMed
6.
go back to reference Cotton MF, Hartzenberg B, Donald PR, Burger PJ (1991) Ventriculoperitoneal shunt infections in children. A 6-year study. S Afr Med J 79:139–142PubMed Cotton MF, Hartzenberg B, Donald PR, Burger PJ (1991) Ventriculoperitoneal shunt infections in children. A 6-year study. S Afr Med J 79:139–142PubMed
7.
go back to reference Drake JM, Kestle JR, Milner R, Cinalli G, Boop F, Piatt J Jr, Haines S, Schiff SJ, Cochrane DD, Steinbok P, MacNeil N (1998) Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 43:294–303, discussion 303–305PubMedCrossRef Drake JM, Kestle JR, Milner R, Cinalli G, Boop F, Piatt J Jr, Haines S, Schiff SJ, Cochrane DD, Steinbok P, MacNeil N (1998) Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 43:294–303, discussion 303–305PubMedCrossRef
8.
go back to reference Fan-Havard P, Nahata MC (1987) Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm 6:866–880PubMed Fan-Havard P, Nahata MC (1987) Treatment and prevention of infections of cerebrospinal fluid shunts. Clin Pharm 6:866–880PubMed
9.
go back to reference Gardner P, Leipzig T, Phillips P (1985) Infections of central nervous system shunts. Med Clin North Am 69:297–314PubMed Gardner P, Leipzig T, Phillips P (1985) Infections of central nervous system shunts. Med Clin North Am 69:297–314PubMed
10.
go back to reference Gardner P, Leipzig TJ, Sadigh M (1988) Infections of mechanical cerebrospinal fluid shunts. Curr Clin Top Infect Dis 9:185–214PubMed Gardner P, Leipzig TJ, Sadigh M (1988) Infections of mechanical cerebrospinal fluid shunts. Curr Clin Top Infect Dis 9:185–214PubMed
11.
go back to reference George R, Leibrock L, Epstein M (1979) Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 51:804–811PubMed George R, Leibrock L, Epstein M (1979) Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 51:804–811PubMed
12.
go back to reference Govender ST, Nathoo N, van Dellen JR (2003) Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831–839PubMed Govender ST, Nathoo N, van Dellen JR (2003) Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 99:831–839PubMed
13.
go back to reference Gray ED, Peters G, Verstegen M, Regelmann WE (1984) Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1:365–367PubMedCrossRef Gray ED, Peters G, Verstegen M, Regelmann WE (1984) Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1:365–367PubMedCrossRef
14.
go back to reference Hampl J, Schierholz J, Jansen B, Aschoff A (1995) In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien) 133:147–152CrossRef Hampl J, Schierholz J, Jansen B, Aschoff A (1995) In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien) 133:147–152CrossRef
15.
go back to reference Ignelzi RJ, Kirsch WM (1975) Follow-up analysis of ventriculoperitoneal and ventriculoatrial shunts for hydrocephalus. J Neurosurg 42:679–682PubMedCrossRef Ignelzi RJ, Kirsch WM (1975) Follow-up analysis of ventriculoperitoneal and ventriculoatrial shunts for hydrocephalus. J Neurosurg 42:679–682PubMedCrossRef
16.
go back to reference James HE, Walsh JW, Wilson HD, Connor JD, Bean JR, Tibbs PA (1980) Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery 7:459–463PubMedCrossRef James HE, Walsh JW, Wilson HD, Connor JD, Bean JR, Tibbs PA (1980) Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery 7:459–463PubMedCrossRef
17.
go back to reference Kestle JR, Drake JM, Cochrane DD, Milner R, Walker ML, Abbott R 3rd, Boop FA, Endoscopic Shunt Insertion Trial participants (2003) Lack of benefit of endoscopic ventriculoperitoneal shunt insertion: a multicenter randomized trial. J Neurosurg 98:284–290PubMed Kestle JR, Drake JM, Cochrane DD, Milner R, Walker ML, Abbott R 3rd, Boop FA, Endoscopic Shunt Insertion Trial participants (2003) Lack of benefit of endoscopic ventriculoperitoneal shunt insertion: a multicenter randomized trial. J Neurosurg 98:284–290PubMed
18.
go back to reference Kestle JR, Garton HJ, Whitehead WE, Drake JM, Kulkarni AV, Cochrane DD, Muszynski C, Walker ML (2006) Management of shunt infections: a multicenter pilot study. J Neurosurg 105:177–181PubMed Kestle JR, Garton HJ, Whitehead WE, Drake JM, Kulkarni AV, Cochrane DD, Muszynski C, Walker ML (2006) Management of shunt infections: a multicenter pilot study. J Neurosurg 105:177–181PubMed
19.
go back to reference Kockro RA, Hampl JA, Jansen B, Peters G, Scheihing M, Giacomelli R, Kunze S, Aschoff A (2000) Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol 49:441–450PubMed Kockro RA, Hampl JA, Jansen B, Peters G, Scheihing M, Giacomelli R, Kunze S, Aschoff A (2000) Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol 49:441–450PubMed
20.
go back to reference Kohnen W, Schaper J, Klein O, Tieke B, Jansen B (1998) A silicone ventricular catheter coated with a combination of rifampin and trimethoprim for the prevention of catheter-related infections. Zentralbl Bakteriol 287:147–156PubMed Kohnen W, Schaper J, Klein O, Tieke B, Jansen B (1998) A silicone ventricular catheter coated with a combination of rifampin and trimethoprim for the prevention of catheter-related infections. Zentralbl Bakteriol 287:147–156PubMed
21.
go back to reference McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ (2003) Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 36:858–862PubMedCrossRef McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ (2003) Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 36:858–862PubMedCrossRef
22.
go back to reference Meirovitch J, Kitai-Cohen Y, Keren G, Fiendler G, Rubinstein E (1987) Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 6:921–924PubMedCrossRef Meirovitch J, Kitai-Cohen Y, Keren G, Fiendler G, Rubinstein E (1987) Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 6:921–924PubMedCrossRef
23.
go back to reference Peters G, Locci R, Pulverer G (1982) Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 146:479–482PubMed Peters G, Locci R, Pulverer G (1982) Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 146:479–482PubMed
24.
go back to reference Schierholz JM, Pulverer G (1997) Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination. Zentralbl Bakteriol 286:107–123PubMed Schierholz JM, Pulverer G (1997) Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination. Zentralbl Bakteriol 286:107–123PubMed
25.
go back to reference Schoenbaum SC, Gardner P, Shillito J (1975) Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 131:543–552PubMed Schoenbaum SC, Gardner P, Shillito J (1975) Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 131:543–552PubMed
26.
go back to reference Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, Jallo GI (2005) Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 103:131–136PubMed Sciubba DM, Stuart RM, McGirt MJ, Woodworth GF, Samdani A, Carson B, Jallo GI (2005) Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 103:131–136PubMed
27.
go back to reference Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP (1984) Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 60:1014–1021PubMed Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP (1984) Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 60:1014–1021PubMed
28.
go back to reference Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP (1985) Decreased risk of infection in cerebrospinal fluid shunt surgery using prophylactic antibiotics: a case-control study. Z Kinderchir 40(Suppl 1):15–18PubMed Walters BC, Hoffman HJ, Hendrick EB, Humphreys RP (1985) Decreased risk of infection in cerebrospinal fluid shunt surgery using prophylactic antibiotics: a case-control study. Z Kinderchir 40(Suppl 1):15–18PubMed
Metadata
Title
Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children
Authors
Peter Kan
John Kestle
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Child's Nervous System / Issue 7/2007
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-007-0296-7

Other articles of this Issue 7/2007

Child's Nervous System 7/2007 Go to the issue